Apeiron RIA’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,607
Closed -$211K 200
2023
Q3
$211K Buy
10,607
+535
+5% +$10.1K 0.07% 183
2023
Q2
$189K Buy
+10,072
New +$203K 0.06% 189
2022
Q4
Sell
-9,825
Closed -$202K 184
2022
Q3
$202K Buy
+9,825
New +$196K 0.09% 165

Other funds holding BTAL

Apeiron RIA's BTAL Position: Q4 2023 in Review

Apeiron RIA sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 10,607 shares — an estimated $211K sold.

Apeiron RIA first reported a position in BTAL in Q3 2022 and held it in 3 quarters. The position peaked at $211K in Q3 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.

  • Apeiron RIA reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
  • Apeiron RIA sold 10,607 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $211K.
  • Apeiron RIA first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2022 and held it in 3 quarters.
  • Apeiron RIA's AGF US Market Neutral Anti-Beta Fund position peaked at $211K in Q3 2023.
  • 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.

Based on Apeiron RIA's 13F filing for Q4 2023, filed 12 Jan 2024.